The ABA Task Force on Law and Artificial Intelligence has released its Year 2 Report on the Impact of AI on the Practice of Law. Here are some highlights.
The post Year 2 Report on the Impact of AI on the Practice of Law from the ABA: Artificial Intelligence Trends appeared first on eDiscovery Today
Key Takeaways from FINRA’s 2026 Annual Regulatory Oversight Report
The Financial Industry Regulatory Authority’s (FINRA) 2026 Annual Regulatory Oversight Report is the most current and comprehensive statement of FINRA’s priorities and expectations for member firms. It does not create new legal obligations, but it is clearly designed as an exam and enforcement roadmap. The 2026 Report weaves together FINRA’s FINRA Forward modernization program, new and evolving risks (especially cyber‑enabled fraud and generative AI (GenAI)), and detailed observations on firms’ supervisory, operational, and financial controls. Firms should use it as a structured checklist for 2026 risk assessments, revisions to written supervisory procedures (WSPs), and enhancements to testing, surveillance, and training.
Executive Order Signals A Push Toward A Single, Federal “AI Rulebook” And A Retreat From The State Patchwork
By Gerald L. Maatman, Jr., Justin R. Donoho, and Hayley Ryan Duane Morris Takeaways: On December 11, 2025, President Donald J. Trump signed Executive Order 14365 titled “Ensuring a National Policy Framework for Artificial Intelligence.” The Order targets what it characterizes as a “patchwork” of State-by-State AI regulation and directs federal agencies to pursue a
Discovery Wake-Up Call: AI Prompts Are Discoverable (And Privacy Won’t Save You)
By Kelly Twigger
Welcome to the final Case of the Week for 2025! As we close out the year and look toward a fantastic 2026, we are doing something a little different. Rather than focusing on a single order, we are diving deep into the OpenAI Copyright MDL in the Southern District
Lights, Camera, Disclosures, Consent: New York’s New AI Laws Take Center Stage
Brands and agencies, take note: Whether or not your commercials are subject to SAG-AFTRA, with these new New York bills, additional disclosures and consents are now required when using synthetic performers and digital replicas in ads.
A Double Feature
On December 11, New York Gov. Kathy Hochul performed a double feature when she signed into
The DOJ Data Security Program: Are You in Compliance?
A New Approach to Data Regulation
With the U.S. Department of Justice’s Data Security Program (DSP) now in full effect, companies that handle sensitive personal data, operate across borders, or rely on global vendor ecosystems face an increasingly complex compliance environment. The DSP restricts certain data transactions involving individuals and countries of concern, imposes new
European Commission Adopts Proposal for the Biotech Act
Introduction
On 16 December 2025, the European Commission (“Commission”) published its Proposal for a Regulation on establishing a framework of measures for strengthening the Union’s biotechnology and biomanufacturing sectors particularly in the area of health (“Biotech Act”) (see here). The Proposal follows a public consultation held between August 2025 and November 2025
Binge-Worthy CLE: The Most Watched Courses of 2025 (5 Days of CLE)
Welcome to Day 3 of our 5 Days of CLE series! Today, we’re spotlighting the programs that thousands of attorneys couldn’t stop watching, and dominated viewing numbers in 2025.
What makes a CLE course truly binge-worthy? It’s the perfect combination of timely relevance, practical insights, and engaging content that keeps you learning long after your
CBCA’s FY 2025 Report – Examining the Numbers
In its recently published FY 2025 Annual Report (Report), the Civilian Board of Contract Appeals (CBCA) provided detailed statistics about appeals involving disputes between contractors and civilian agencies. This past year, the civilian agencies with the highest number of docketed claims at the Board were the Department of Veterans Affairs (70 appeals), the United States Agency for International Development (43 appeals), the General Services Administration (36 appeals), the Department of State (12 appeals ), and the Department of Education (12 appeals). These agencies accounted for 173, or approximately 78%, of the 221 Contract Disputes Act (CDA) appeals docketed at the Board.
From complexity to clarity: How the EU Commission plans to overhaul the MDR and IVDR
Introduction
The European Commission has published its proposals on the amendment of the Medical Devices Regulation 2017/745 (MDR) and In Vitro Diagnostic Regulation 2017/746 (IVDR) (“the proposals”). This marks a pivotal moment for the EU healthcare and MedTech landscape, following a public consultation by the Commission in early 2025 (see our blog here) and a call for evidence in September 2025 (see our blog here). The proposals respond to industry concerns over complexity, cost, and delays which have been substantially hammering the MedTech industry since the implementation of the MDR and IVDR.
The proposals aim to streamline regulatory processes, reduce administrative burden, and enhance predictability, while maintaining patient safety and public health. From adaptive pathways for breakthrough and orphan devices to leaner conformity assessments, stronger notified body (NB) governance, and changes to classification, these changes are designed to future-proof the regulatory framework and foster innovation. For manufacturers, healthcare institutions, innovators, and industry stakeholders, the proposals signal a shift toward a more proportionate, risk-based system that supports timely access to critical technologies without compromising quality.
Below, we have set out an overview of some of the key proposals. Additionally, while not released with the proposals, the European Commission published a draft Implementing Regulation on certain uniform quality management and procedural requirements for the conformity assessment activities carried out by Notified Bodies – see our separate blog on this here.
The proposals have now been submitted to the European Parliament and Council for review. Once the Parliament and Council have adopted their own positions on the text, there will be negotiations to agree a final text which can be formally adopted by the Council and the Parliament. At this stage, it is challenging to anticipate what would be the result of the political negotiations and unclear when the new rules will start to apply.
A feedback period has been opened, running from 7 January to 5 March 2026. All feedback received will be summarised by the Commission and presented to the European Parliament and Council with the aim of feeding into the legislative debate.